Career Enhancement Program

摘要 国家努力降低乳腺癌发病率和死亡率的长期成功在一定程度上取决于 乳腺癌孢子项目吸引和打造人才翻译研究事业的能力 年轻的教员。自1992年以来，北卡罗来纳大学乳腺癌孢子分会一直利用职业发展基金促进 选定研究人员的乳腺癌研究生涯。孢子职业提升计划 (CEP)既从外部招聘，又确定对转化性乳腺癌研究感兴趣的内部教员。 然后，CEP将初级教员与培训课程和高级导师相匹配。我们寻求丰富这一领域 我们努力招募合格的妇女和少数族裔作为该计划的参与者和导师。 在该计划的24年中，由CEP资助的招聘人员包括17名女性和6名少数族裔教员(3名 非洲裔美国人，三名西班牙裔美国人)。与校园各部门联合招聘吸引优秀人才 北卡罗来纳大学及其癌症中心。孢子CEP为初级教职员工提供扩展培训 由受人尊敬和成功的调查人员组成的互动小组，他们可以影响和帮助建立职业生涯。这个 优秀的人才库与有效的培训和指导计划相结合，造就了一批精英 乳腺癌研究人员的干部，他们的工作为全国乳腺癌工作做出了贡献。 在过去六年中，CEP吸引了13名参与者；其中5名是妇女，3名是少数民族。我们 特别高兴的是，13名新人中有6人被评为科门职业催化剂学者(还有一人 DRP Awardee)和几家已经得到NCI的资助。这些CEP参与者的贡献包括 已发表的研究、资助的赠款和跨人群的乳腺癌合作研究， 基础、临床和转化性研究。在CEP计划的过程中，许多参与者 成为孢子领袖。这些人包括开发CBCS的鲍勃·米利根、查尔斯·佩鲁、多PI和联合- 项目3负责人；Lisa Carey联合项目负责人兼项目1、3和职业生涯的联合负责人 增强计划；梅丽莎·特罗斯特，项目1的联合负责人；凯里·安德斯，项目的临床试验负责人 #4；克莱尔·迪斯是项目2的联合调查员，凯蒂·霍德利是项目1、3的联合调查员，还有 生物信息学/生物统计学核心。 在接下来的五年里，北卡罗来纳大学的乳腺癌孢子将继续推动和发展事业 转译乳腺癌研究。北卡罗来纳州立大学乳腺癌孢子分会要求5万美元支持职业生涯 发展。这些资金将与每年400-60万美元的机构资金相结合，以提供 转化型乳腺癌研究教师的招聘和职业发展。孢子领袖将会 继续确定、招聘和发展少数民族和女性教职员工。

Abstract The long-term success of national efforts to reduce breast cancer incidence and mortality rests in part on the ability of Breast Cancer SPORE programs to attract and build the translational research careers of talented young faculty. Since 1992, the UNC Breast Cancer SPORE has used career development funds to promote the breast cancer research careers of selected investigators. The SPORE Career Enhancement Program (CEP) both recruits externally and identifies internal faculty with interest in translational breast cancer research. The CEP then matches junior faculty with training offerings and senior mentors. We seek to enrich the field with our efforts to recruit qualified women and minorities as both participants and mentors in the program. Over the 24 years of the program recruits funded by the CEP include 17 women and six minority faculty (three African Americans, three Hispanic). Co-recruitment with departments across campus attracts exceptional talent to UNC and its Cancer Center. The SPORE CEP makes available extended training for junior faculty with an interactive group of respected and successful investigators who can influence and help build careers. The combination of an excellent talent pool and an effective training and mentoring program has resulted in an elite cadre of breast cancer researchers whose work contributes to the national breast cancer effort. Over the last six years the CEP has attracted 13 participants; five were women and three were minorities. We are particularly pleased that six of the 13 recruits were named Komen Career Catalyst Scholars (as was one DRP Awardee) and several have already been funded by NCI. These CEP participants’ contributions include published research, funded grants and collaborative breast cancer research across the spectrum of population, basic, clinical and translational research. Over the course of the CEP program a number of participants have become SPORE leaders. These include Bob Millikan, who developed CBCS; Charles Perou, Multi-PI and co- leader of Project 3; Lisa Carey Co-program head and co-leader of Projects 1 and 3 and the Career Enhancement Program; Melissa Troester, co-leader of Project 1; Carey Anders, clinical trial leader of Project #4; Claire Dees co-investigator on Project #2 and Katie Hoadley co-investigator Project #1, #3 and the Bioinformatics / Biostatistics Core. Over the next five years, the UNC Breast Cancer SPORE will continue to promote and develop careers in translational breast cancer research. The UNC Breast Cancer SPORE requests $50,000 to support career development. These funds will combine with $400-600,000 yearly in institutional funds to provide for recruitment and career development of faculty in translational breast cancer research. The SPORE leaders will continue to identify, recruit, and develop minority and women faculty.